c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma-Reference-Cited by-同舟云学术

c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma

Published:2016-12 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Kim Ha-Jeong,Yoon Aera,Ryu Ji-Yoon,Cho Young-Jae,Choi Jung-Joo,Song Sang Yong,Bang Heejin,Lee Ji Soo,Cho William Chi,Choi Chel Hun,Lee Jeong-Won,Kim Byoung-Gie,Bae Duk-Soo

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep38502.pdf

Reference42 articles.

1. Chang, S. J., Bristow, R. E., Chi, D. S. & Cliby, W. A. Role of aggressive surgical cytoreduction in advanced ovarian cancer. J Gynecol Oncol 26, 336–342 (2015).

2. Prat, J. Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features. Virchows Arch 460, 237–249 (2012).

3. Tan, D. S. & Kaye, S. Ovarian clear cell adenocarcinoma: a continuing enigma. J Clin Pathol 60, 355–360 (2007).

4. Ho, C. M. et al. Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease. Gynecol Oncol 94, 197–203 (2004).

5. Lee, Y. Y. et al. Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: a meta-analysis. Gynecol Oncol 122, 541–547 (2011).

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocyte growth factor promotes retinal pigment epithelium cell activity through MET/AKT signaling pathway;International Journal of Ophthalmology;2024-05-18

2. MET overexpression in ovarian cancer via CD24‐induced downregulation of miR‐181a: A signalling for cellular quiescence‐like state and chemoresistance in ovarian CSCs;Cell Proliferation;2023-11-29

3. Ovarian Clear Cell Carcinoma: Genomic Characterization, Pathogenesis and Targeted Therapy;Anticancer Research;2023-07-26

4. Secreted Soluble Factors from Tumor-Activated Mesenchymal Stromal Cells Confer Platinum Chemoresistance to Ovarian Cancer Cells;International Journal of Molecular Sciences;2023-04-23

5. Secreted soluble factors from tumor-activated mesenchymal stromal cells confer platinum chemoresistance to ovarian cancer cells;2023-02-26